人类对甲型流感疫苗接种的细胞毒性T细胞反应。
The human cytotoxic T cell response to influenza A vaccination.
作者信息
McMichael A J, Gotch F, Cullen P, Askonas B, Webster R G
出版信息
Clin Exp Immunol. 1981 Feb;43(2):276-84.
Abstract
The human cytotoxic T lymphocyte (CTL) response to challenge with influenza A vaccine was studied. Six of eight volunteers given killed whole influenza virus A/USSR (H1N1) vaccine showed substantial increases on the level of CTL memory 1 month after immunization. The CTL measured at this time showed complete cross-reactivity in their specificity for influenza A/USSR (H1N1) and A/X31 (H3N2) infected cells and also showed HLA restriction. The level of CTL memory increased in only three out of nine donors given subunit vaccine and showed no change in those not given vaccine. If cytotoxic T cells are important in influenza prophylaxis, killed whole virus vaccine should offer better protection than subunit vaccine.
摘要
对甲型流感疫苗激发的人类细胞毒性T淋巴细胞（CTL）反应进行了研究。八名接种甲型流感病毒A/苏联（H1N1）灭活全病毒疫苗的志愿者中，有六人在免疫后1个月时CTL记忆水平显著升高。此时检测到的CTL对感染甲型流感病毒A/苏联（H1N1）和A/X31（H3N2）的细胞具有完全交叉反应性，并且还表现出HLA限制性。九名接种亚单位疫苗的供体中只有三人的CTL记忆水平有所升高，而未接种疫苗的供体则无变化。如果细胞毒性T细胞在流感预防中起重要作用，那么灭活全病毒疫苗应比亚单位疫苗提供更好的保护。
相似文献
1
The human cytotoxic T cell response to influenza A vaccination.人类对甲型流感疫苗接种的细胞毒性T细胞反应。
Clin Exp Immunol. 1981 Feb;43(2):276-84.
2
Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice.流感病毒疫苗在小鼠中诱导的交叉保护和交叉反应性细胞毒性T细胞。
Eur J Immunol. 1980 May;10(5):396-401. doi: 10.1002/eji.1830100515.
3
Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?6至23个月大儿童的流感疫苗免疫原性：启动免疫是否需要相同抗原？
Pediatrics. 2006 Sep;118(3):e570-8. doi: 10.1542/peds.2006-0198.
4
Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.由FLU-ISCOM疫苗在小鼠中诱导产生的针对人类甲型流感病毒（包括最近出现的禽流感H5和H9病毒）的异源亚型免疫需要细胞毒性T淋巴细胞和巨噬细胞功能。
Cell Immunol. 2001 Aug 1;211(2):143-53. doi: 10.1006/cimm.2001.1835.
5
Cytotoxic T lymphocyte responses of infants after natural infection or immunization with live cold-recombinant or inactivated influenza A virus vaccine.
J Med Virol. 1996 Oct;50(2):105-11. doi: 10.1002/(SICI)1096-9071(199610)50:2<105::AID-JMV1>3.0.CO;2-E.
6
Augmentation of human influenza A virus-specific cytotoxic T lymphocyte memory by influenza vaccine and adjuvanted carriers (ISCOMS).流感疫苗和佐剂载体（免疫刺激复合物）增强甲型人流感病毒特异性细胞毒性T淋巴细胞记忆
Virology. 1999 Jul 5;259(2):256-61. doi: 10.1006/viro.1999.9765.
7
Cytotoxic T-cell response to influenza A subunit vaccine in patients with type 1 diabetes mellitus.
Neth J Med. 1989 Aug;35(1-2):68-75.
8
Cloned lines of human cytotoxic T lymphocytes with specificity for influenza virus.对流感病毒具有特异性的人细胞毒性T淋巴细胞克隆系。
J Immunol. 1982 Oct;129(4):1731-5.
9
Humoral and cellular immune responses in children given annual immunization with trivalent inactivated influenza vaccine.每年接种三价灭活流感疫苗的儿童的体液免疫和细胞免疫反应。
Pediatr Infect Dis J. 2007 Feb;26(2):107-15. doi: 10.1097/01.inf.0000253251.03785.9b.
10
Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine.接种季节性流感疫苗后对新型甲型H1N1流感病毒的血清交叉反应抗体应答。
MMWR Morb Mortal Wkly Rep. 2009 May 22;58(19):521-4.
引用本文的文献
1
Efficacy of an Inactivated Whole-Virus A/Victoria/361/2011 (IVR-165) (H3N2) Influenza Vaccine in Ferrets.一种灭活全病毒A/维多利亚/361/2011（IVR-165）（H3N2）流感疫苗在雪貂中的效力
Microbiol Immunol. 2024 Dec;68(12):427-437. doi: 10.1111/1348-0421.13179. Epub 2024 Nov 8.
2
In silico formulation of a next-generation multiepitope vaccine for use as a prophylactic candidate against Crimean-Congo hemorrhagic fever.基于计算机的克里米亚-刚果出血热新一代多表位疫苗的配方设计，用作预防性候选药物。
BMC Med. 2023 Feb 1;21(1):36. doi: 10.1186/s12916-023-02750-9.
3
Understanding the Role of HLA Class I Molecules in the Immune Response to Influenza Infection and Rational Design of a Peptide-Based Vaccine.了解 HLA I 类分子在流感感染免疫反应中的作用及基于肽的疫苗的合理设计。
Viruses. 2022 Nov 21;14(11):2578. doi: 10.3390/v14112578.
4
Balanced Cellular and Humoral Immune Responses Targeting Multiple Antigens in Adults Receiving a Quadrivalent Inactivated Influenza Vaccine.在接受四价灭活流感疫苗的成年人中，针对多种抗原的平衡细胞免疫和体液免疫反应
Vaccines (Basel). 2021 Apr 23;9(5):426. doi: 10.3390/vaccines9050426.
5
Legacy of the influenza pandemic 1918: The host T cell response.1918 年流感大流行的遗留问题：宿主 T 细胞反应。
Biomed J. 2018 Aug;41(4):242-248. doi: 10.1016/j.bj.2018.08.003. Epub 2018 Sep 11.
6
Natural T Cell-mediated Protection against Seasonal and Pandemic Influenza. Results of the Flu Watch Cohort Study.天然T细胞介导的针对季节性流感和大流行性流感的保护作用。流感观察队列研究结果
Am J Respir Crit Care Med. 2015 Jun 15;191(12):1422-31. doi: 10.1164/rccm.201411-1988OC.
7
Immunity to influenza. Preventing infection and regulating disease.
Am J Respir Crit Care Med. 2015 Feb 1;191(3):248-51. doi: 10.1164/rccm.201412-2245ED.
8
Different arms of the adaptive immune system induced by a combination vaccine work in concert to provide enhanced clearance of influenza.联合疫苗诱导的适应性免疫系统的不同分支协同作用，以增强流感病毒的清除。
PLoS One. 2014 Dec 18;9(12):e115356. doi: 10.1371/journal.pone.0115356. eCollection 2014.
9
Harnessing alveolar macrophages for sustained mucosal T-cell recall confers long-term protection to mice against lethal influenza challenge without clinical disease.利用肺泡巨噬细胞进行持续的黏膜 T 细胞回忆，可在不引起临床疾病的情况下为小鼠提供针对致命性流感挑战的长期保护。
Mucosal Immunol. 2014 Jan;7(1):89-100. doi: 10.1038/mi.2013.27. Epub 2013 May 29.
10
Towards a universal influenza vaccine: volunteer virus challenge studies in quarantine to speed the development and subsequent licensing.迈向通用流感疫苗：检疫中的志愿者病毒挑战研究以加速开发和随后的许可。
Br J Clin Pharmacol. 2013 Aug;76(2):210-6. doi: 10.1111/bcp.12146.
本文引用的文献
1
Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice.流感病毒疫苗在小鼠中诱导的交叉保护和交叉反应性细胞毒性T细胞。
Eur J Immunol. 1980 May;10(5):396-401. doi: 10.1002/eji.1830100515.
2
The effects of shifts and drifts on the epidemiology of influenza in man.
Philos Trans R Soc Lond B Biol Sci. 1980 Feb 25;288(1029):423-32. doi: 10.1098/rstb.1980.0019.
3
Studies with inactivated influenza vaccines purified by zonal centrifugation. 2. Efficacy.采用区带离心法纯化的灭活流感疫苗的研究。2. 效力。
Bull World Health Organ. 1969;41(3):531-5.
4
Antigenic drift and efficacy of influenza virus vaccines, 1976--1977.
J Infect Dis. 1978 Nov;138(5):618-24. doi: 10.1093/infdis/138.5.618.
5
HLA-linked genetic control of the specicity of human cytotoxic T-cell responses to influenza virus.人类细胞毒性T细胞对流感病毒反应特异性的HLA连锁基因控制
J Exp Med. 1979 Mar 1;149(3):565-75. doi: 10.1084/jem.149.3.565.
6
HLA restriction of human cytotoxic T lymphocytes specific for influenza virus. Poor recognition of virus associated with HLA A2.针对流感病毒的人类细胞毒性T淋巴细胞的HLA限制。与HLA A2相关的病毒识别能力较差。
J Exp Med. 1978 Dec 1;148(6):1458-67. doi: 10.1084/jem.148.6.1458.
7
Influenza virus-specific cytotoxic T cells in man; induction and properties of the cytotoxic cell.人体内流感病毒特异性细胞毒性T细胞；细胞毒性细胞的诱导及特性
Eur J Immunol. 1978 Oct;8(10):705-11. doi: 10.1002/eji.1830081007.
8
Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus.特异性细胞毒性T淋巴细胞的转移可保护接种流感病毒的小鼠。
Nature. 1978 May 18;273(5659):238-9. doi: 10.1038/273238a0.
9
Cytotoxic T cells in the lungs of mice infected with an influenza A virus.感染甲型流感病毒的小鼠肺部的细胞毒性T细胞。
Scand J Immunol. 1978;7(1):73-80. doi: 10.1111/j.1365-3083.1978.tb00428.x.
10
Immunologic recognition of influenza virus-infected cells. I. Generation of a virus-strain specific and a cross-reactive subpopulation of cytotoxic T cells in the response to type A influenza viruses of different subtypes.流感病毒感染细胞的免疫识别。I. 针对不同亚型甲型流感病毒的应答中，细胞毒性T细胞的病毒株特异性和交叉反应性亚群的产生。
Cell Immunol. 1977 Oct;33(2):423-36. doi: 10.1016/0008-8749(77)90170-8.
Zotero 插件